AMP-224, a PD-1 Inhibitor, With Stereotactic Body Radiation Therapy in Metastatic Colorectal Cancer
Clinical trial NCT02298946 · COMPLETED
Trial details
- NCT number
- NCT02298946
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-21
- Primary completion
- 2016-07-13
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.